Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 05 September, 2009 and appeared in  Issue 485Cardiovascular HealthType 1 Diabetes

Being Short Linked with Diabetic Complications

Being short in adulthood is associated with an increased risk of microvascular complications in patients with Type 1 diabetes, according to a report.

Advertisement

Short stature in adults has been associated with hypertension, early arterial stiffening, cardiovascular disease, impaired glucose tolerance, and other disorders of glucose metabolism, the authors explain, but the association between short stature and diabetic complications is uncertain.

To determine whether such an association exists, Dr. Johan Waden from Folkhalsan Research Center, Helsinki, Finland, and colleagues in the Finnish Diabetic Nephropathy (FinnDiane) Study Group analyzed 3,968 adults from the FinnDiane study and 1,246 adults from the Diabetes Control and Complications Trial (DCCT), all with Type 1 diabetes. 

In multiple logistic regression analyses, short stature in the FinnDiane study was independently associated with diabetic nephropathy and laser-treated retinopathy. After adjustment for years of diabetes exposure during the years of linear growth, however, adult stature was no longer associated with nephropathy or retinopathy. 

In the DCCT cohort, short stature was associated with more than a doubling of the risks for nephropathy and retinopathy. In this population, more patients had diabetes onset after age 18, and the association with renal sequelae was independent of childhood diabetes exposure. In a Cox regression model, however, short stature was not independently associated with retinopathy. 

"This study indicates that short adult stature is associated with higher prevalence and incidence of microvascular complications in patients with Type 1 diabetes," the investigators conclude. "Understanding the mechanisms underlying these associations could identify novel preventative strategies." 

Diabetes Aug. 2009;58:1914-1920.

 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 05 September, 2009 and appeared in  Issue 485Cardiovascular HealthType 1 Diabetes

Past five issues: Diabetes Clinical Mastery Series Issue 85 | Issue 626 | Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 |

 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

Navigate Diabetes In Control
Announcement:
Search Articles On Diabetes In Control